Marker Therapeutics Inc (MRKR)

[Inoviorulez]

Short-sellers will do everything in their power to bring it down on low volume. However, the way I view it is the more shorts there are the bigger the squeeze if the PC data is solid. They will propel MRKR higher if they are forced to cover at higher prices.

I pointed out the other day that there were about

27,337,350 shares short before the Pfizer buyout of Array Biopharma. That's crazy when you think about it.